Why JLKAX Lagged Its Benchmark by 5 Basis Points in Q1

The John Hancock Multimanager 2050 Lifetime Portfolio (JLKAX) returned -1.75% in the first quarter of 2026, trailing the S&P Target Date 2050 Index by 5 basis points. That gap is small. The cause matters more than the size for anyone assessing whether this fund's construction works in a shifting macro environment.

Asset allocation drove the shortfall. Underlying manager performance contributed positively. That distinction separates a portfolio-construction issue from a manager-skill problem. The miss sits in the weightings, not the stock picks.

Q1 2026: The Growth-Style Drag on JLKAX

The first quarter delivered mixed returns across asset classes. The damage concentrated in two overlapping exposures: the growth style and mega-cap U.S. technology stocks. March's downturn, triggered by the escalating conflict in the Middle East, hit global equity indexes broadly. JLKAX's negative equity return came mostly from those two pockets.

A 2050 target-date fund like JLKAX carries a steep equity allocation with a natural growth bias. That bias generated strong returns in the prior bull run. It turned into a liability when growth stocks re-rated downward in March. The benchmark, the S&P Target Date 2050 Index, likely holds a similar growth tilt. The 5-bp gap shows that JLKAX's specific portfolio construction – the exact blend of sub-asset classes and managers – lagged the index allocation even before the worst of the sell-off hit.

Manager Performance Added Value – The Better Read

The surprising detail in this quarter's commentary is that underlying manager performance contributed positively to relative returns. The individual portfolio managers running the equity, fixed-income, and alternative sleeves within JLKAX made stock-picking calls that added alpha. The strategic asset allocation dragged down the total.

This is the mechanism worth tracking. If the asset allocation decision is the culprit, the gap should shrink or reverse when the market factor that caused it – growth-style underperformance – fades. If manager selection had been the problem, the underperformance would be more structural. Because it is an allocation gap, the fund's long-dated horizon (2050) makes a single quarter's shortfall irrelevant for a buy-and-hold investor. The risk is that the allocation stays overweight growth into a prolonged value or defensive rotation.

What This Means for JLKAX Holders

For an investor mapping out a taxable or retirement watchlist, the takeaway is straightforward. The underperformance is not a red flag. It is a clue about how the fund behaves in a risk-off environment. The fund's multimanager structure – John Hancock selects third-party specialists – is supposed to buffer against exactly this kind of factor concentration. That it did not in Q1 2026 suggests the glide path's equity bucket leaned too heavily into the growth/mega-cap stack relative to the index.

The Next Decision Point for JLKAX

The fund's next quarterly commentary will show whether the asset allocation drag continues or reverses. Two scenarios to track:

• A stabilization or recovery in growth stocks would likely close the 5-bp gap, making Q1 a one-off.
• A further sell-off in mega-cap tech would widen the spread and raise questions about the fund's active tilts within the equity sleeve.

For now, the Q1 report does not change the fundamental thesis. JLKAX is a low-cost, multimanager target-date vehicle with a long-dated horizon. The 5-bp lag is a footnote, not a flag. The cause – growth-style concentration – is worth monitoring because it touches every target-date fund with a similar profile. Investors should compare JLKAX's quarterly performance breakdown to peers like Vanguard Target Retirement 2050 or Fidelity Freedom 2050 to see if the allocation drag is fund-specific or industry-wide.

The broader context for this quarter is that the Middle East conflict compressed equity risk premiums in March. The funds most exposed to long-duration growth stories – which include nearly every 2050 target-date fund – felt the most pain. JLKAX's 5-bp gap is not a crisis. The mechanism behind it deserves attention in the second quarter.